fourteen women with ovulatory menstrual cycles were treated with a superactive agonistic analog of gonadotropin-releasing hormone ( 6-d- [ 2-naphthyl ] -alanyl ) -gnrh ( nafarelin ) .
C0023610
gnrh
C0064906
nafarelin